Managing Quality of Life with CML
Understanding chronic myeloid leukemia Chronic myeloid leukaemia (CML) is a type of cancer that develops in the blood-forming…
Merck’s $6.7B Terns Acquisition Positions It to Challenge a Blockbuster Novartis Cancer Drug
Merck is picking up a big new piece for its cancer drug pipeline with a $6.7 billion deal…
25 Year Anniversary of Innovation in Treating CML
Twenty-Five Years of Community: How Living With CML Has Changed—and Brought Patients Together Discussion notes from the Second…
Roche to Present 46 Abstracts, 12 Orals at ASH Meeting
Roche (OTCQX: RHHBY) will present 46 abstracts, including 12 oral presentations, at ASH…
Roche Receives Conditional Authorisation for Lunsumio SC
Roche (OTCQX: RHHBY) announced the European Commission granted conditional marketing authorisation for Lunsumio…